Drug Profile
NPI 1999
Latest Information Update: 24 Apr 2007
Price :
$50
*
At a glance
- Originator NovoScience Pharma
- Class
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 24 Apr 2007 No development reported - Preclinical for Thrombosis in Canada (unspecified route)
- 19 Feb 2003 Preclinical trials in Thrombosis in Canada (unspecified route)